dc.contributor.author | Peled, Nir | |
dc.contributor.author | Gillis, Roni | |
dc.contributor.author | Kılıçkap, Saadettin | |
dc.contributor.author | Froesch, Patrizia | |
dc.contributor.author | Orlov, Sergei | |
dc.contributor.author | Filippova, Elena | |
dc.contributor.author | Demirci, Umut | |
dc.contributor.author | Christopoulos, Petros | |
dc.contributor.author | Çiçin, İrfan | |
dc.contributor.author | Buğdaycı Basal, Fatma | |
dc.contributor.author | Yılmaz, Cengiz | |
dc.contributor.author | Fedor, Moiseenko | |
dc.contributor.author | Korkmaz, Taner | |
dc.contributor.author | Paydaş, Semra | |
dc.contributor.author | Gautschi, Oliver | |
dc.contributor.author | Zırtıloğlu, Alişan | |
dc.contributor.author | Eralp, Yeşim | |
dc.contributor.author | Yeşil Çınkır, Havva | |
dc.contributor.author | Sezer, Ahmet | |
dc.contributor.author | Erman, Mustafa | |
dc.contributor.author | Tural, Deniz | |
dc.contributor.author | Turna, Hande | |
dc.contributor.author | Mazieres, Julien | |
dc.contributor.author | Dudnik, Elizabeth | |
dc.contributor.author | Reguart, Noemi | |
dc.contributor.author | Camidge, David Ross | |
dc.contributor.author | Ng, Terry L. | |
dc.contributor.author | Çay Şenler, Filiz | |
dc.contributor.author | Beypınar, İsmail | |
dc.contributor.author | Yazılıtaş, Doğan | |
dc.contributor.author | Demirkazık, Ahmet | |
dc.contributor.author | Karaoğlu, Aziz | |
dc.contributor.author | Okutur, Kerem | |
dc.contributor.author | Coşkun, Hasan Şenol | |
dc.contributor.author | Şendur, Mehmet Ali Nahit | |
dc.contributor.author | Işıkdoğan, Abdurrahman | |
dc.contributor.author | Çabuk, Devrim | |
dc.contributor.author | Yumuk, Perran Fulden | |
dc.contributor.author | Yıldız, İbrahim | |
dc.contributor.author | Kaplan, Mehmet Ali | |
dc.contributor.author | Özyılkan, Özgür | |
dc.contributor.author | Öztop, İlhan | |
dc.contributor.author | Ölmez, Ömer Fatih | |
dc.contributor.author | Aydın, Kübra | |
dc.contributor.author | Aydıner, Adnan | |
dc.contributor.author | Meydan, Nezih | |
dc.contributor.author | Grinberg, Roxana Denisa | |
dc.contributor.author | Roisman, Laila C. | |
dc.date.accessioned | 2021-05-07T08:32:43Z | |
dc.date.available | 2021-05-07T08:32:43Z | |
dc.date.issued | 2021 | en_US |
dc.identifier.citation | Peled, N., Gillis, R., Kılıçkap, S., Froesch, P., Orlov, S., Filippova, E. ... Roisman, L. C. (2021). Glass: Global lorlatinib for ALK(+) and ROS1(+) retrospective study: Real world data of 123 NSCLC patients. Journal of Thoracic Oncology içinde (S656-S656. ss.). | en_US |
dc.identifier.issn | 1556-0864 | |
dc.identifier.issn | 1556-1380 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/6823 | |
dc.description.abstract | Introduction: Lorlatinib is a third-generation tyrosine-kinases inhibitor (TKI) targeting ALK/ROS1 fusions. The FDA has approved lorlatinib for TKI-pretreated ALK(+) NSCLC, while its approval for ROS1(+) is still pending. Here we present the largest real-world data of NSCLC patients harboring ALK/ROS1 rearrangements treated with lorlatinib. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | ROS1(+) | en_US |
dc.subject | ALK(+) | en_US |
dc.subject | Lorlatinib | en_US |
dc.title | Glass: Global lorlatinib for ALK(+) and ROS1(+) retrospective study: Real world data of 123 NSCLC patients | en_US |
dc.type | conferenceObject | en_US |
dc.relation.ispartof | Journal of Thoracic Oncology | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
dc.authorid | 0000-0001-7934-7039 | en_US |
dc.identifier.volume | 16 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | S656 | en_US |
dc.identifier.endpage | S656 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.identifier.wosquality | Q1 | en_US |